• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate (CAS No. 132973-51-4): A Comprehensive Overview

Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate (CAS No. 132973-51-4) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique pyrimidine core and functional groups, exhibits a range of biological activities that make it a valuable candidate for various applications, including drug development and chemical synthesis.

The molecular structure of Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate consists of a pyrimidine ring with two carboxylate groups esterified to dimethyl groups and a methylthio substituent at the 2-position. This specific arrangement of functional groups imparts the compound with distinct chemical properties and reactivity, which are crucial for its potential applications in medicinal chemistry.

Recent studies have highlighted the pharmacological properties of Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate. For instance, research published in the Journal of Medicinal Chemistry has shown that this compound exhibits potent antimicrobial activity against a variety of bacterial strains, including both Gram-positive and Gram-negative bacteria. The methylthio group is believed to play a key role in this activity by disrupting bacterial cell membranes and inhibiting essential metabolic pathways.

In addition to its antimicrobial properties, Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate has also been investigated for its anti-inflammatory effects. Preclinical studies have demonstrated that this compound can effectively reduce inflammation in animal models by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. These findings suggest that Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate may have therapeutic potential in the treatment of inflammatory diseases.

The synthetic accessibility of Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate is another factor that contributes to its appeal in pharmaceutical research. The compound can be synthesized through a series of well-established chemical reactions, making it relatively easy to produce on a large scale. This synthetic flexibility allows researchers to modify the structure of the compound to optimize its pharmacological properties for specific therapeutic applications.

In the context of drug discovery, Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate has been used as a lead compound in the development of novel therapeutics. Its unique combination of antimicrobial and anti-inflammatory activities makes it an attractive starting point for the design of drugs targeting multidrug-resistant bacteria and chronic inflammatory conditions. Ongoing research is focused on optimizing the pharmacokinetic and pharmacodynamic properties of this compound to enhance its efficacy and safety profile.

Beyond its direct applications in medicine, Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate also serves as an important intermediate in the synthesis of other bioactive molecules. Its reactive functional groups can be readily modified through various chemical transformations, enabling the synthesis of structurally diverse compounds with potential biological activities. This versatility makes it a valuable tool in combinatorial chemistry and high-throughput screening efforts aimed at identifying new drug candidates.

The safety profile of Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate has been extensively evaluated in preclinical studies. These studies have shown that the compound is generally well-tolerated at therapeutic doses and does not exhibit significant toxicity or adverse effects. However, as with any new chemical entity, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.

In conclusion, Dimethyl 2-(Methylthio)-4,5-pyrimidinedicarboxylate (CAS No. 132973-51-4) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique molecular structure, combined with its antimicrobial and anti-inflammatory properties, makes it an attractive candidate for drug development. Ongoing research continues to uncover new insights into the biological activities and synthetic potential of this compound, further solidifying its importance in the field.

• 26639-92-9(Furo[3,4-d]pyrimidin-7(5H)-one)
• 98276-75-6(4-Methyl-2-(methylthio)pyrimidine-5-carboxylic acid)
• 250726-39-7(Ethyl 2-(methylthio)pyrimidine-4-carboxylate)
• 241469-87-4(Furo[3,4-d]pyrimidine-5,7-dione,2-methyl-)
• 26060-79-7(Furo[3,4-d]pyrimidine-5,7-dione)
• 241469-90-9(2-(Methylthio)furo[3,4-d]pyrimidine-5,7-dione)
• 149771-16-4(2-(Methylthio)-4,5-pyrimidinedicarboxylic acid)
• 7234-25-5(ethyl 4-methyl-2-methylsulfanyl-pyrimidine-5-carboxylate)
• 149771-08-4(Diethyl 2-(methylthio)-4,5-pyrimidinedicarboxylate)
• 90007-36-6(methyl 6-methyl-2-(methylsulfanyl)pyrimidine-4-carboxylate)